Subscribe to: Heart Care Info RSS Feed  

Heart Care Info - Heart Disease Prevention & Treatment

  Heart health     Cardiopathy     Heart study     Cardiology      Email A Friend  
Heart disease
Heart attack
Heart failure
Heart surgery
Heart Care Info
Heart transplantation
Bypass surgery
Cardiovascular disease
Arrhythmia
Atherosclerosis
Heart rate
Cardiac arrest
Cardiac death
Cardiac surgery
Cardiovascular system
Cardiomyopathy
Endocarditis
Cardiomegaly
Myocarditis


coronary intervention with drug 8208 eluting stents versus bypass surgery for patients with left main or three 8208 vessel coronary artery disease One 8208 year results from the, coronary artery disease

... coronary intervention with drug‐eluting stents versus bypass surgery for patients with left main or three‐vessel coronary artery disease: One‐year results from the ...


Heart Care Guide - http://www.heartcareguide.net

DJ Cohen, TA Lavelle, B Van Hout... - Catheterization and ..., 2011 - Wiley Online Library Objectives: To evaluate the cost-effectiveness of alternative approaches to revascularization for patients with three-vessel or left main coronary artery disease (CAD). Background: Previous studies have demonstrated that, despite higher initial costs, long-term costs with ...

Objectives: To evaluate the cost effectiveness of alternative approaches to revascularization for patients with three vessel or left main coronary artery disease (CAD). Background: Previous studies have demonstrated that, despite higher initial costs, long term costs with bypass surgery (CABG) in multivessel CAD are similar to those for percutaneous coronary intervention (PCI). The impact of drug eluting stents (DES) on these results is unknown. Methods: The SYNTAX trial randomized 1,800 patients with left main or three vessel CAD to either CABG (n = 897) or PCI using paclitaxel eluting stents (n = 903). Resource utilization data were collected prospectively for all patients, and cumulative 1 year costs were assessed from the perspective of the U.S. healthcare system. Results: Total costs for the initial hospitalization were $5,693/patient higher with CABG, whereas follow up costs were $2,282/patient higher with PCI due mainly to more frequent revascularization procedures and higher outpatient medication costs. Total 1 year costs were thus $3,590/patient higher with CABG, while quality adjusted life expectancy was slightly higher with PCI. Although PCI was an economically dominant strategy for the overall population, cost effectiveness varied considerably according to angiographic complexity. For patients with high angiographic complexity (SYNTAX score > 32), total 1 year costs were similar for CABG and PCI, and the incremental cost effectiveness ratio for CABG was $43,486 per quality adjusted life year gained. Conclusions: Among patients with three vessel or left main CAD, PCI is an economically attractive strategy over the first year for patients with low and moderate angiographic complexity, while CABG is favored among patients with high angiographic complexity. 2011 Wiley Periodicals, Inc.

More Details:

... coronary intervention with drug‐eluting stents versus bypass surgery for patients with left main or three‐vessel coronary artery disease: One‐year results from the ...
Cardiovascular health
Cardiovascular surgery
Coronary artery disease
Coronary artery bypass graft

Subscribe to Heart Care Info by Email
Your email address:

Heart Care Guide
Life & Health Center
Find Doctor in Town
Health Care Jobs
Heart disease treatment